Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-opens-phase-i-clinical-trial-centre-to-step-up-new-drug-development-in-hong-kong
https://www.med.cuhk.edu.hk/press-releases/cuhk-opens-phase-i-clinical-trial-centre-to-step-up-new-drug-development-in-hong-kong

CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

18 December 2013 Commissioned by the Food and Health Bureau of the Hong Kong SAR Government, The Chinese University of Hong Kong (CUHK) has established the Phase I Clinical Trial Centre (CTC) to strengthen clinical research and development of new drugs in Hong Kong and Asia.  The opening ceremony was held today (18 December), officiated by Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; Prof. Jiang Ji, Director, Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital; Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK; and Prof. Anthony T.C. Chan, Chief Director, Phase I Clinical Trial Centre, CUHK, and joined by over 300 guests.  

 

Located at 11EF in the Prince of Wales Hospital, the CUHK Phase I Clinical Trial Centre is established with three objectives: 1) to become an internationally recognized centre of excellence for the development of new drugs by recruiting patients with special medical needs and healthy volunteers to participate in the research; 2) to boost the competitiveness of Hong Kong in drug research and development by fostering partnerships with academic institutions and the pharmaceutical industry in clinical research; and 3) to promote knowledge transfer and education amongst health care professionals in early phase drug development in Hong Kong and the region.  

 

(From left) Prof. Anthony T.C. Chan, Chief Director, Phase I Clinical Trial Centre, CUHK; Prof. Jiang Ji, Director, Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital; Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; and Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK officiate at the Grand Opening of CUHK Phase I Clinical Trial Centre.

(From left) Prof. Anthony T.C. Chan, Chief Director, Phase I Clinical Trial Centre, CUHK; Prof. Jiang Ji, Director, Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital; Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; and Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK officiate at the Grand Opening of CUHK Phase I Clinical Trial Centre.

 

 

At the ceremony, Prof. Joseph Sung, Vice-Chancellor and President, CUHK said, ‘I must extend our gratitude to all those who have contributed to making this Phase I CTC possible, especially the Food and Health Bureau and the Department of Health of the HKSAR Government, as well as the Hospital Authority.  I am proud of the achievements of the phase I researchers in CUHK and I believe they will continue to strive for excellence, contributing to the well-being of mankind.’  

 

Over the past decades, the introduction of new drugs has provided more and better therapeutic options for various diseases such as cancer and diabetes.  The development of a new drug has to undergo at least 7 years of rigorous clinical trials in human subjects, requiring the participation of a large number of volunteers at different stages of research.   Phase I clinical trial is the first and critical step in this arduous process that brings drugs from the laboratory to clinical application.  It determines the safest and most biologically effective dosage of new drugs, facilitating the large-scale evaluation in phase II and III trials.  In the past, phase I trials were almost exclusively conducted in the West where most new drugs are introduced.  Recently, more multi-national pharmaceutical companies and academic institutions have relocated their R&D operations to Asia, focusing on the development of new drugs for Asian-prevalent diseases such as diabetes, viral hepatitis and certain types of cancer.  The demand for early phase clinical trial centres with related professionals and facilities thus greatly increases.  

 

The CUHK Phase I Clinical Trial Centre boasts a seasoned research team with over 10 years’ experience and remarkable research achievements in the field.  The Centre has established extensive network with academic and pharmaceutical partners and is well-positioned to develop into the regional hub of phase I clinical trials.  

 

Prof. Francis Chan, Dean, Faculty of Medicine (centre); Prof. Anthony Chan, Chief Director (left) and Dr. Brigette Ma, Medical Director, Phase I Clinical Trial Centre, CUHK express the gratitude to the support from the Food and Health Bureau and the Department of Health of the HKSAR Government, Hospital Authority, the researchers and in particular the volunteers for their selfless contribution and unstinting participation in making the early phase clinical trials at the Faculty possible, leading to the advances in medical science.

Prof. Francis Chan, Dean, Faculty of Medicine (centre); Prof. Anthony Chan, Chief Director (left) and Dr. Brigette Ma, Medical Director, Phase I Clinical Trial Centre, CUHK express the gratitude to the support from the Food and Health Bureau and the Department of Health of the HKSAR Government, Hospital Authority, the researchers and in particular the volunteers for their selfless contribution and unstinting participation in making the early phase clinical trials at the Faculty possible, leading to the advances in medical science.

 

Prof. Francis Chan, Dean, Faculty of Medicine, CUHK said, ‘The CUHK Faculty of Medicine is committed to translating academic research to clinical applications to improve the effectiveness of therapies.  We look forward to expanding our collaboration with pharmaceutical and biotechnology companies on drug and medical development.’  

 

The safety of research participants is the first priority of CUHK Phase I Clinical Centre.  The Centre is equipped with 36-bed inpatient facility and mobile medical monitoring and surveillance.  Each bed has its own dedicated resuscitation apparatus and emergency alarms.  The storage facility for drugs and tissue samples is equipped with temperature and humidity control systems.  The Hospital Authority will support the Centre by providing emergency services of the Prince of Wales Hospital.  The patient-centered approach of the Centre is also reflected in the cozy design of the entertainment area with internet access, audio-visual equipment and other ‘homely’ facilities.       

 

Prof. Anthony Chan, Chief Director of the Phase I Clinical Trial Centre said, ‘The fundamental principle of conducting research in human subjects in all phases is to safeguard the safety and welfare of each study participant.  We are indebted to the participants for their selfless contribution and participation in clinical trials, leading to the advances in medical science.’

 

Located at 11EF in the Prince of Wales Hospital, the CUHK Phase I Clinical Trial Centre is equipped with 36-bed inpatient facility and mobile medical monitoring and surveillance that the study subjects can be observed from both nursing stations and staff common room to ensure patient safety.

Located at 11EF in the Prince of Wales Hospital, the CUHK Phase I Clinical Trial Centre is equipped with 36-bed inpatient facility and mobile medical monitoring and surveillance that the study subjects can be observed from both nursing stations and staff common room to ensure patient safety.

The patient-centered approach of the Centre is reflected in the cozy design of the Entertainment Room with internet access, audio-visual equipment and other ‘homely’ facilities.

The patient-centered approach of the Centre is reflected in the cozy design of the Entertainment Room with internet access, audio-visual equipment and other ‘homely’ facilities.

 

More Press Releases

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

CUHK and International Experts in Diabetes Care Joined Hands for Four Years Developing a Multicomponent, Integrated Strategy for Diabetes under The Lancet

International collaboration
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CUHK Study Sees the Exposure to Farm Environment  Is Beneficial for Children to Prevent Asthma

CUHK Study Sees the Exposure to Farm Environment Is Beneficial for Children to Prevent Asthma

Research
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Multicomponent Frailty Prevention Programme Reduces Frailty Over 80% of Pre-frail Elderly Reverse to Robust Phenotype

Research
CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

Research
CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

Research
CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

CUHK Asia’s First Comprehensive Epidemiological Study on Health Impact of Household Cleaning Products on Children Reveals Frequent Use of Household Cleaning Products Increase Risk of Triggering Rhinitis in Children

Research
CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

CUHK and HKU Researchers Introduce 3D Printing Technology in Complex Cardiac Surgery Procedures

Research
CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

Research
CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK/International Study Implicates a Gene in Alzheimer’s disease

CUHK/International Study Implicates a Gene in Alzheimer’s disease

Research
CUHK Launches Hong Kong’s First Pilot Integrative Medicine Programme in Multiple Sclerosis for Managing Cognitive Symptoms, Relieving Fatigue, and Disease Control

CUHK Launches Hong Kong’s First Pilot Integrative Medicine Programme in Multiple Sclerosis for Managing Cognitive Symptoms, Relieving Fatigue, and Disease Control

Research
Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
CUHK Introduces New Material for Osteoporosis-related Bone Fracture Effectively Reduces Healing Time and Enhances Bone Strength Both by 30%

CUHK Introduces New Material for Osteoporosis-related Bone Fracture Effectively Reduces Healing Time and Enhances Bone Strength Both by 30%

Research
CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

Research
CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

Research
CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

CUHK Advocates Stringent Control of Cardiovascular Risks for Reopening of Narrowed Brain Arteries - A New Paradigm to Prevent Recurrent Stroke (Available in Chinese only)

Research
CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

CUHK Latest Research Reveals over 100,000 New Non-alcoholic Fatty Liver Cases in Hong Kong Annually

Research
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

CUHK Research by Medical Undergraduates Reveals Poor Medication Adherence Among Hypertensive Patients in Hong Kong

Research
CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

CUHK Study Reveals Peer Support Can Reduce Hospital Admission of Distressed Diabetes Patients

Research
Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Research
Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Screening Reveals Over 50% Community-dwelling Population Aged 65 or above are Pre-frail

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Survey Reveals Relationship between Exercise Pattern and Emotional Health among Hong Kong People Mind-body Exercise Helps Reduce Risk of Mood Disorders

CUHK Survey Reveals Relationship between Exercise Pattern and Emotional Health among Hong Kong People Mind-body Exercise Helps Reduce Risk of Mood Disorders

Research
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

CUHK Releases Research Results on Employment Status of Hong Kong Chronic Kidney Disease (CKD) Dialysis Patients and Promotes Predialysis Education Programme for Mid to Late Stage CKD patients

Research
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
CUHK Announces Latest Medical Treatment for Minor Stroke

CUHK Announces Latest Medical Treatment for Minor Stroke

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

Research
CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

CUHK Research Reveals that Physical and Cognitive Activities can Maintain and Improve Brain Functions of Patients with Mild Cognitive Impairments

Research
CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

CUHK Launches Territory-wide Screening Study for Early Detection of Nasopharynx Cancer Now Recruiting 20,000 Citizens to Join

Research
CUHK Research Reveals Impact of Mild Hearing Loss on School Children Now Recruiting Hearing Impaired Students for Research on Efficacy of Intervention

CUHK Research Reveals Impact of Mild Hearing Loss on School Children Now Recruiting Hearing Impaired Students for Research on Efficacy of Intervention

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.